Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review)
Oncology Reports · 2026
DOI: 10.3892/or.2026.9044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, 2026. Verfasst von Upesh Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Proto-Oncogene Proteins p21(ras), Lung Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116021, P.R. China.
Zitieren
APA
Sharma, U., Song, J., Kandu, H., Zhu, Y., & Dai, Z. (2026). Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review). Oncology Reports. https://doi.org/10.3892/or.2026.9044
Vancouver
Sharma U, Song J, Kandu H, Zhu Y, Dai Z. Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review). Oncology Reports. 2026. doi:10.3892/or.2026.9044
BibTeX
@article{Sharma2026,
author = {Sharma, Upesh and Song, Jincheng and Kandu, Hemraj and Zhu, Yue and Dai, Zhaoxia},
title = {Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review)},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9044}
}
EUVIMED